Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
4
57%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Enrolling by invitation1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (20.0%)
N/A4 (80.0%)

Trials by Status

enrolling_by_invitation114%
not_yet_recruiting114%
terminated114%
completed457%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7